Epigenomic regulation in congenital anomaly syndromes
Project/Area Number |
26670490
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Pediatrics
|
Research Institution | Tohoku University |
Principal Investigator |
Aoki Yoko 東北大学, 医学(系)研究科(研究院), 教授 (80332500)
|
Co-Investigator(Kenkyū-buntansha) |
MATSUBARA Yoichi 国立研究開発法人国立成育医療研究センター, 研究所, 所長 (00209602)
NIIHORI Tetsuya 東北大学, 大学院医学系研究科, 准教授 (40436134)
INOUE Shinichi 東北大学, 大学院医学系研究科, 助教 (70622091)
|
Research Collaborator |
YAOITA Masako 東北大学, 大学院医学系研究科
OBA Daiju 東北大学, 大学院医学系研究科
NISHIYAMA Ayumi 東北大学, 大学院医学系研究科
UMEKI Ikumi 東北大学, 大学院医学系研究科
TAKAHARA Shingo 東北大学, 大学院医学系研究科
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | ヌーナン症候群 / RAS / エピゲノム / RAS/MAPシグナル伝達経路 / RAS/MAPK / BRAF |
Outline of Final Research Achievements |
In this study, we analyzed genes that are associated with epigenetic modifications in patients, who are clinically diagnosed as having RASopathies, and identified pathogenic mutations in three affected individuals. We generated a knock-in mice expressing a Braf p.Q241R mutation, as a model mice for CFC syndrome. Treatment with a MEK inhibitor, PD0325901, and a histone H3K27 demethylase inhibitor, GSK-J4, have rescued embryonic lethality in BrafQ241R/+ mice. To explore the mechanisms of efficacy in PD0325901 and GSK-J4 co-treatment, we examined mRNA and protein levels of histone H3K27 methylase and histone H3K27 demethylases in heart tissues from control and BrafQ241R/+ embryos. Further analysis on methylation profiling of H3K27 in each gene will clarify the mechanisms why co-treatment of PD0325901 and GSK-J4 rescued the embryonic lethality in in BrafQ241R/+ mice.
|
Report
(3 results)
Research Products
(13 results)
-
[Journal Article] Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.2016
Author(s)
Yaoita M, Niihori T, Mizuno S, Okamoto N, Hayashi S, Watanabe A, Yokozawa M, Suzumura H, Nakahara A, Nakano Y, Hokosaki T, Ohmori A, Sawada H, Migita O, Mima A, Lapunzina P, Santos-Simarro F, García-Miñaúr S, Ogata T, Kawame H, Kurosawa K, Ohashi H, Inoue S, Matsubara Y, Kure S, Aoki Y.
-
Journal Title
Hum Genet.
Volume: 135
Issue: 2
Pages: 209-222
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.2015
Author(s)
Moriya M, Inoue S, Miyagawa-Tomita S, Nakashima Y, Oba D, Niihori T, Hashi M, Ohnishi H, Kure S, Matsubara Y, Aoki Y.
-
Journal Title
Hum Mol Genet.
Volume: 24
Issue: 25
Pages: 7349-7360
DOI
Related Report
Peer Reviewed
-
[Journal Article] Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities.2015
Author(s)
Watanabe Y, Shido K, Niihori T, Niizuma H, Katata Y, Iizuka C, Oba D, Moriya K, Saito-Nanjo Y, Onuma M, Rikiishi T, Sasahara Y, Watanabe M, Aiba S, Saito R, Sonoda Y, Tominaga T, Aoki Y, Kure S.
-
Journal Title
Am J Med Genet A.
Volume: 170
Issue: 1
Pages: 189-194
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Bilateral giant coronary aneurysms in a 40-year-old male with Noonan syndrome caused by a KRAS germline mutation.2014
Author(s)
Fujimoto N, Nakajima H, Sugiura E, Dohi K, Kanemitsu S, Yamada N, Aoki Y, Nakatani K, Shimpo H, Nobori T, Ito M
-
Journal Title
Int J Cadiol
Volume: 173
Issue: 3
Pages: e63-e66
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-